Merck KGaA
XETRA:MRK
Merck KGaA
XETRA:MRK
Price:
165.65 EUR
4.64%
Market Closed
Updated:
May 15, 2024
Merck KGaA
Income from Continuing Operations
|
Merck KGaA
Income from Continuing Operations Peer Comparison
Comparables:
ATAI
BAYN
93M1
DMP
PSG
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Merck KGaA
XETRA:MRK
|
Income from Continuing Operations
€2.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Income from Continuing Operations
-$40.3m
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
Income from Continuing Operations
-€2.9B
|
CAGR 3-Years
43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
MPH Health Care AG
XETRA:93M1
|
Income from Continuing Operations
€29.1m
|
CAGR 3-Years
38%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Income from Continuing Operations
€60.5m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Income from Continuing Operations
€12m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is Merck KGaA's Income from Continuing Operations?
Income from Continuing Operations
2.8B
EUR
2.8B
EUR
Based on the financial report for Dec 31, 2023, Merck KGaA's Income from Continuing Operations amounts to 2.8B EUR.
What is Merck KGaA's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
9%
9%
Over the last year, the Income from Continuing Operations growth was -15%. The average annual Income from Continuing Operations growth rates for Merck KGaA have been 12% over the past three years , 21% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
